Single-Port SHURUI Robotic Thoracic Surgery
Official title: Thoracic Surgery by SHURUI Single-Port Surgical Robot: A Prospective Single Centre Study
Run by Chinese University of Hong Kong · NCT07255703 · Data updated 2026-11-12
This observational study tests the SHURUI single-port robotic system during thoracic surgery to see if it can reduce trauma and speed recovery in adults needing lung or mediastinal procedures.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Shatin) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | November 1, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07255703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-75 years old planned for lobectomy, segmentectomy, wedge resection, or mediastinal tumor resection who are eligible for general anesthesia and meet surgical indications.
✕Probably not a fit
Patients with prior thoracic surgery, significant comorbidities, or unsuitable anatomy or health status may not experience benefit and could be at higher risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the SHURUI single-port surgical robot (SR-ENS-600) used in thoracic and related surgeries. Eligible adults aged 18-75 with resectable lung cancers, oligometastatic lung disease, or mediastinal tumors may undergo endoscopic procedures with the robotic system. The investigation focuses on surgical feasibility, safety, and perioperative outcomes in a real-world clinical setting. Procedures involve limited-incision, single-port access to improve precision and potentially shorten recovery. Data collection includes standard perioperative metrics and patient outcomes, without a specified intervention arm since this is observational.
Why it matters
Potential benefit: If successful, patients may experience less tissue trauma, fewer complications, and faster recovery after thoracic procedures using the SHURUI SP system.
How similar studies have gone: Prior reports suggest single-port robotic approaches can reduce invasiveness and recovery time, though evidence quality varies and this may be among early regional experiences.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Age between 18 - 75 years; 2. Subjects need to undergo endoscopic surgery and meet one of the following indications for surgical treatment: * Lobectomy, segmentectomy wedge resection of lung: Clinically diagnosed resectable early stage non-small cell lung carcinoma; oligometastatic cancer to the lung; * Mediastinal mass resection: Clinically diagnosed mediastinal tumour (benign or malignant) that are indicated for resection; 3. Preoperative ASA grade: Grade I-III; 4. Subject voluntarily participates in the clinical trial, and agrees or his/her guardian agrees and signs the informed consent. Exclusion criteria: 1. Subjects with a previous history of thoracic surgery or other malignant tumor which, in the judgement of the investigator, make them unsuitable for enrolment; 2. Subjects with severe co-morbidities or organ dysfunction (heart, lung, liver, brain, kidney, etc.) or deemed too weak/ unsuitable for general anesthesia or operation; 3. Non-correctable coagulopathy and severe bleeding tendency; 4. Emergency surgery; 5. Severe obesity with BMI ≥30 kg/m2; 6. Subjects with severe allergic constitution, suspected or confirmed alcohol, drug addiction; 7. Other circumstances in which the investigator considered participation in this clinical trial inappropriate.
Where it's running
-
Prince of Wales Hospital
Shatin, Hong Kong Recruiting
Study contacts
- Study coordinator: Calvin Sze Hang Ng
- Email: calvinng@surgery.cuhk.edu.hk
- Phone: +852 3505 2618
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AirGo Respiratory Monitoring During Lung Resection
Patients undergoing lung resection will wear the AirGo device to continuously monitor breathing before and after surgery to see if it helps track ventilation alongside standard checks.
-
Frailty-focused prehabilitation before heart surgery
This study tests a home-based, frailty-tailored prehabilitation program for adults 65+ waiting 5 weeks or more for heart surgery to see if it improves fitness, frailty, heart-related function, nutrition, inflammation, quality of life, and hospital outcomes.
-
Wireless home prehabilitation for older adults with NSCLC awaiting lung surgery
This study tests whether a personalized home exercise program guided by wearable devices can improve lung function for older NSCLC patients preparing for curative lung surgery.
-
Transdermal buprenorphine patch added to multimodal pain relief after VATS
This study tests whether adding a 5 mcg/hour buprenorphine patch to standard pain relief after unilateral VATS reduces pain in adults.
-
Continuous ESP Block vs Thoracic Epidural for Preventing Chronic Pain After Thoracotomy
This study compares whether a continuous erector spinae plane block can better prevent chronic post-thoracotomy pain than the current standard thoracic epidural analgesia in adults undergoing elective thoracic surgery.
-
SPSIP vs RISS Block for pain relief after volume-preserving VATS
This randomized trial tests whether the SPSIP block can better control chest pain after VATS than the RISS block in adults undergoing lung-preserving surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.